Product
FOLFIRINOX Bevacizumab
1 clinical trial
1 indication
Indication
Colorectal CancerClinical trial
Phase I / II Study Evaluating the Efficacy and Safety of FOLFIRINOX3 Bevacizumab Treatment in Patients With Colorectal Cancer Who Have Failed With Standard Chemotherapy Protocols (FOLFIRINOX 3)Status: Active (not recruiting), Estimated PCD: 2024-11-21